Literature DB >> 18726078

[Blood clots in erythrocyte concentrates during transfusion].

T Wagner1, C Drexler, W Kröll, G Jüngling, G Lanzer, C Gabriel.   

Abstract

BACKGROUND: The presence of multiple blood clots in leucocyte-depleted erythrocyte concentrates during a transfusion gave rise to an investigation to find the exact cause.
MATERIALS AND METHODS: Determination of the various blood group systems was carried out using the gel centrifugation method and also the polymerase chain reaction (PCR) using sequence-specific primers. In addition the human leucocyte antigens (HLA) class 1 and class 2 markers were determined with molecular biological methods.
RESULTS: The erythrocytes in the blood bags containing the blood clots showed a mixed-field agglutination in each blood group where the donor and recipient had different phenotypes. The HLA groups, however, could be solely attributed to the patient, since during the preparation of erythrocyte concentrates all leucocytes are removed and only very few residual cells containing DNA are present.
CONCLUSIONS: To the best of our knowledge, this is the first detailed report on blood clots from patient blood in erythrocyte concentrates, which occurred during a transfusion. The retrograde filling of the blood bag with patient blood during the transfusion led to coagulation in the bag. Therefore, careful attention must be taken when dealing with stored blood and corresponding training must be regularly carried out.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726078     DOI: 10.1007/s00101-008-1444-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  11 in total

Review 1.  The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance.

Authors:  L Williamson; H Cohen; E Love; H Jones; A Todd; K Soldan
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

Review 2.  Immunological aspects of blood transfusions.

Authors:  Anneke Brand
Journal:  Transpl Immunol       Date:  2002-08       Impact factor: 1.708

3.  A report of 104 transfusion errors in New York State.

Authors:  J V Linden; B Paul; K P Dressler
Journal:  Transfusion       Date:  1992-09       Impact factor: 3.157

4.  Recipient-derived clots in red blood cells during transfusion.

Authors:  Thomas Wagner; Susanne Macher; Wolfgang Kröll; Gerhard Jüngling; Gerhard Lanzer; Christian Gabriel
Journal:  Transfusion       Date:  2006-09       Impact factor: 3.157

Review 5.  Non-infectious complications of transfusion therapy.

Authors:  P L Perrotta; E L Snyder
Journal:  Blood Rev       Date:  2001-06       Impact factor: 8.250

6.  Low propidium iodide intensity in flow cytometric white blood cell counting as a marker of cell destruction?

Authors:  Thomas Wagner; Sylvia E Guber; Maria-Luise Stubenrauch; Gerhard Lanzer; Josef Neumueller
Journal:  Transfusion       Date:  2005-02       Impact factor: 3.157

Review 7.  Risks associated with transfusion of cellular blood components in Canada.

Authors:  Steven Kleinman; Penny Chan; Pierre Robillard
Journal:  Transfus Med Rev       Date:  2003-04

Review 8.  Transfusion-transmitted bacterial infection: risks, sources and interventions.

Authors:  S J Wagner
Journal:  Vox Sang       Date:  2004-04       Impact factor: 2.144

Review 9.  The risks associated with blood and blood product transfusion.

Authors:  C Higgins
Journal:  Br J Nurs       Date:  2000 Dec 8-2001 Jan 10

10.  HLA-B*27 typing by group-specific hybridization in microtiter plates.

Authors:  T Wagner; C Oberkanins; B Weinmayr; W Helmberg; F Kury; G Lanzer
Journal:  Tissue Antigens       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.